This Psychedelic Biotech Play Could See a Leg Up After Encouraging LSD Trials
The speculative action is cooling but individual names keep working.
The speculative action is cooling but individual names keep working.
The market is in a transitional phase as we await earnings.
I’m heavily weighted in this one sector, while adding to one name on news.
I’m still finding things to buy. Here’s what I’ve been up to.
Today saw a rise in new highs on the NYSE, but there were still about 20% fewer than just two weeks ago.